HomeInsightsPE

Sanjivani Paranteral Ltd PE Ratio

Sanjivani Paranteral Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 6, 2024)

stocks purchased

2.6 K

Stocks Traded

(Dec 6, 2024)

Last Updated on: Dec 07, 2024

Image

Sanjivani Paranteral Ltd

NSE: SANJIVPARANT

PE

52.2

Last updated on: Dec 07, 2024

Key Highlights

  • The P/E Ratio of Sanjivani Paranteral Ltd is 52.2 as of 07 Dec 9.00 AM .
  • The P/E Ratio of Sanjivani Paranteral Ltd changed from 6.6 on March 2021 to 28.4 on March 2024 . This represents a CAGR of 44.03% over 4 years.
  • The Latest Trading Price of Sanjivani Paranteral Ltd is ₹ 308.75 as of 06 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Sanjivani Paranteral Ltd

No data available

Company Fundamentals for Sanjivani Paranteral Ltd

No data available

Image

Sanjivani Paranteral Ltd

NSE: SANJIVPARANT

Share Price

₹ 308.75

6.05 (2.00%)

stock direction

Last updated on: Dec 06, 2024

Market Price of Sanjivani Paranteral Ltd

1M

1Y

3Y

5Y

Monitoring Sanjivani Paranteral Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
06 Dec 2024308.75
05 Dec 2024302.7
04 Dec 2024296.8
03 Dec 2024291
02 Dec 2024292.5
29 Nov 2024286.95
28 Nov 2024284.2
27 Nov 2024290
26 Nov 2024295
25 Nov 2024289.85

SWOT Analysis Of Sanjivani Paranteral Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Sanjivani Paranteral Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Sanjivani Paranteral Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Key Valuation Metric of Sanjivani Paranteral Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Sanjivani Paranteral Ltd

No data available

* All values are in crore

Historical Revenue of Sanjivani Paranteral Ltd

No data available

* All values are in crore

Historical EBITDA of Sanjivani Paranteral Ltd

No data available

* All values are in crore

Historical Net Profit of Sanjivani Paranteral Ltd

No data available

* All values are in crore

Historical Dividend Payout of Sanjivani Paranteral Ltd

No data available

* All values are in %

About Sanjivani Paranteral Ltd

  • Sanjivani Paranteral Ltd is a WHO-GMP certified core pharmaceutical company and a pioneer in the manufacturing of injectables and oral solids with an extensive experience spanning two-and-a-half-decades.
  • The Company primarily focus on life-saving drugs and has exports to over 25 countries, while catering to the needs of a vast geographic area through two WHO-GMP certified manufacturing facilities in Mumbai and Dehradun. Incorporated as a public limited company in Oct.'94, Sanjivani Parenteral was jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry.
  • The Company has been involved in the manufacturing of pharmaceutical medicines.
  • The Company's products includes oral solids, small volume parenteral and sterile powder formulations. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative.

Sanjivani Paranteral Ltd News Hub

News

Sanjivani Paranteral AGM scheduled

Sanjivani Paranteral announced that the 30th Annual General Meeting (AGM) of the company w...

Read more

2024-08-12 00:00:00

News

Sanjivani Paranteral standalone net profit rises 10.32% in the June 2024 quarter

Net profit of Sanjivani Paranteral rose 10.32% to Rs 1.71 crore in the quarter ended June ...

Read more

2024-08-06 00:00:00

News

Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 9 Sep...

Read more

2024-09-05 00:00:00

News

Sanjivani Paranteral announces board meeting date

Sanjivani Paranteral will hold a meeting of the Board of Directors of the Company on 28 Oc...

Read more

2024-10-22 00:00:00

News

Sanjivani Paranteral standalone net profit rises 34.50% in the September 2024 quarter

Net profit of Sanjivani Paranteral rose 34.50% to Rs 2.30 crore in the quarter ended Septe...

Read more

2024-10-28 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Sanjivani Paranteral Ltd

What is the current PE Ratio of Sanjivani Paranteral Ltd?

The Current PE Ratio of Sanjivani Paranteral Ltd is 52.15 as on 7 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 7 Dec 2024.

What was the PE Ratio of Sanjivani Paranteral Ltd last year?

The PE Ratio of Sanjivani Paranteral Ltd was 9.19 last year, now the PE ratio is 52.15, showing a year-on-year growth of 467.5%.

What does the PE Ratio of Sanjivani Paranteral Ltd indicate about its stock?

The PE Ratio of Sanjivani Paranteral Ltd is 52.15. This ratio indicates that investors are willing to pay 52.15 times the earnings per share for each share of Sanjivani Paranteral Ltd.

What is the PE Ratio Growth of Sanjivani Paranteral Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Sanjivani Paranteral Ltd grew by 467.5% whereas, the EPS ratio grew by 33.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions